Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200414879> ?p ?o ?g. }
- W4200414879 endingPage "105" @default.
- W4200414879 startingPage "67" @default.
- W4200414879 abstract "Background: Colorectal cancer (CRC) is a widespread tumour type amongst men and women. Despite the available screening tests, advanced stage CRC is the most frequent diagnosis. It is treated with cytotoxic chemotherapeutics 5-fluorouracil (5-FU), oxaliplatin (Ox) and irinotecan (CPT-11) that eventually lose their effectiveness as chemoresistance develops. Methods: In this review, the compilation and analysis of PUBMED-retrieved literature data was comprehensively presented and some novel and/or previously poorly described molecular features of CRC unresponsiveness to conventional chemotherapy drugs identified using bioinformatics approach. Complex interactions between previously reported biomarkers of resistance to 5-FU, Ox and CPT-11 were analysed by STRING and cytoHubba accompanied by KEGG pathway enrichment analysis using DAVID functional annotation tool. Results: The bioinformatics analysis has revealed that 5-FU affects ribosome biogenesis and functioning (translational activity), leading to colon cancer cells resistance to 5-FU. Unresponsiveness of CRC to Ox was associated with Rap1 signalling pathway, which opens the possibility of using RAP1A inhibitors as an adjuvant to oxaliplatin in CRC. Furthermore, stem cell markers c-Myc and CD44 as well as Akt kinase emerged as novel resistance biomarkers whose pharmacological targeting could elevate the therapeutic efficacy of irinotecan. Lastly, several pathways common to the resistance to all three drugs were revealed, including miRNAs in cancer, proteoglycans in cancer, cellular senescence and the sphingolipid signalling pathway. Conclusion: This paper gives a comprehensive overview of resistance mechanisms to 5-FU, Ox and irinotecan in colon cancer and reveals several novel molecular players and associated mechanisms that could account for the development of chemoresistance and whose targeting might enable the design of novel combination strategies to overcome resistance to conventional treatment in CRC." @default.
- W4200414879 created "2021-12-31" @default.
- W4200414879 creator A5017929347 @default.
- W4200414879 creator A5079142893 @default.
- W4200414879 date "2021-09-01" @default.
- W4200414879 modified "2023-10-16" @default.
- W4200414879 title "Chemoresistance Mechanisms in Colon Cancer: Focus on Conventional Chemotherapy" @default.
- W4200414879 cites W1646607682 @default.
- W4200414879 cites W1748915756 @default.
- W4200414879 cites W1816471535 @default.
- W4200414879 cites W1976681623 @default.
- W4200414879 cites W1980247729 @default.
- W4200414879 cites W1984328540 @default.
- W4200414879 cites W1989012283 @default.
- W4200414879 cites W1995169322 @default.
- W4200414879 cites W2028593825 @default.
- W4200414879 cites W2043028930 @default.
- W4200414879 cites W2050971199 @default.
- W4200414879 cites W2054616520 @default.
- W4200414879 cites W2058057347 @default.
- W4200414879 cites W2058208039 @default.
- W4200414879 cites W2066881731 @default.
- W4200414879 cites W2080142245 @default.
- W4200414879 cites W2098008269 @default.
- W4200414879 cites W2099221592 @default.
- W4200414879 cites W2103912979 @default.
- W4200414879 cites W2112055293 @default.
- W4200414879 cites W2142807621 @default.
- W4200414879 cites W2143519202 @default.
- W4200414879 cites W2146074098 @default.
- W4200414879 cites W2160518775 @default.
- W4200414879 cites W2160624529 @default.
- W4200414879 cites W2177850607 @default.
- W4200414879 cites W2274106006 @default.
- W4200414879 cites W2294760922 @default.
- W4200414879 cites W2342160849 @default.
- W4200414879 cites W2479714960 @default.
- W4200414879 cites W2514126271 @default.
- W4200414879 cites W2554895128 @default.
- W4200414879 cites W2563046503 @default.
- W4200414879 cites W2611200163 @default.
- W4200414879 cites W2615920181 @default.
- W4200414879 cites W2624685411 @default.
- W4200414879 cites W2728184191 @default.
- W4200414879 cites W2743319580 @default.
- W4200414879 cites W2756355820 @default.
- W4200414879 cites W2765346518 @default.
- W4200414879 cites W2767736941 @default.
- W4200414879 cites W2769551956 @default.
- W4200414879 cites W2771056161 @default.
- W4200414879 cites W2771119973 @default.
- W4200414879 cites W2784239137 @default.
- W4200414879 cites W2790789566 @default.
- W4200414879 cites W2796200410 @default.
- W4200414879 cites W2809837556 @default.
- W4200414879 cites W2810971566 @default.
- W4200414879 cites W2887274813 @default.
- W4200414879 cites W2887458491 @default.
- W4200414879 cites W2896429168 @default.
- W4200414879 cites W2916341463 @default.
- W4200414879 cites W2921269539 @default.
- W4200414879 cites W2947574880 @default.
- W4200414879 cites W2965787757 @default.
- W4200414879 cites W2969964427 @default.
- W4200414879 cites W2992670754 @default.
- W4200414879 cites W2996789446 @default.
- W4200414879 cites W3007064358 @default.
- W4200414879 cites W3011481749 @default.
- W4200414879 cites W3026925297 @default.
- W4200414879 cites W4250478397 @default.
- W4200414879 doi "https://doi.org/10.2174/2212697x08666211206102503" @default.
- W4200414879 hasPublicationYear "2021" @default.
- W4200414879 type Work @default.
- W4200414879 citedByCount "0" @default.
- W4200414879 crossrefType "journal-article" @default.
- W4200414879 hasAuthorship W4200414879A5017929347 @default.
- W4200414879 hasAuthorship W4200414879A5079142893 @default.
- W4200414879 hasConcept C121608353 @default.
- W4200414879 hasConcept C126322002 @default.
- W4200414879 hasConcept C143998085 @default.
- W4200414879 hasConcept C1491633281 @default.
- W4200414879 hasConcept C2780259306 @default.
- W4200414879 hasConcept C2780932548 @default.
- W4200414879 hasConcept C2780962732 @default.
- W4200414879 hasConcept C502942594 @default.
- W4200414879 hasConcept C526805850 @default.
- W4200414879 hasConcept C54355233 @default.
- W4200414879 hasConcept C60644358 @default.
- W4200414879 hasConcept C71924100 @default.
- W4200414879 hasConcept C86803240 @default.
- W4200414879 hasConceptScore W4200414879C121608353 @default.
- W4200414879 hasConceptScore W4200414879C126322002 @default.
- W4200414879 hasConceptScore W4200414879C143998085 @default.
- W4200414879 hasConceptScore W4200414879C1491633281 @default.
- W4200414879 hasConceptScore W4200414879C2780259306 @default.
- W4200414879 hasConceptScore W4200414879C2780932548 @default.
- W4200414879 hasConceptScore W4200414879C2780962732 @default.
- W4200414879 hasConceptScore W4200414879C502942594 @default.